Browse the evidence

Cluster set configurations (brief intraset rest) elicit similar myokine (IL-6 and IL-15) responses to traditional sets during resistance exercise, suggesting that cluster sets can promote similar metabolic and immunological adaptations (such as lean mass gains) while potentially offering greater power adaptations.

If you are struggling to complete heavy squats, try breaking your sets into smaller chunks (cluster sets) with short rests. This study shows you get the same muscle-building signals (myokines) as doing the full set, but it might help you lift more powerfully. It's a valid alternative to traditional sets.

Patients taking GLP-1 receptor agonists or dual GIP/GLP-1 agonists should continue these medications through the peri-operative period rather than withholding them, as evidence suggests withholding is insufficient to reduce aspiration risk.

If you take a GLP-1 or GIP/GLP-1 drug (like Ozempic, Wegovy, Mounjaro, Trulicity) for your upcoming elective surgery, do NOT stop taking it. Stopping it for a week or even three weeks does not guarantee your stomach is empty and may not reduce aspiration risk. Instead, tell your anesthesia team you are taking it so they can use specific techniques (like ultrasound or specific intubation methods) to keep you safe.

Patients taking SGLT2 inhibitors should omit these medications the day before and the day of surgery to prevent euglycemic diabetic ketoacidosis (DKA).

If you take an SGLT2 inhibitor (like Jardiance, Farxiga, or Invokana) for your upcoming elective surgery, stop taking it the day before your surgery and do not take it on the day of surgery. This is critical to prevent a rare but serious condition called euglycemic DKA. Your medical team will monitor your blood sugar closely during your stay and manage it with insulin if necessary, which is the safest approach.

Pre-operative administration of carbohydrate-rich fluids (12.5% solution, 400-800 mL) attenuates post-operative insulin resistance and endogenous glucose release, potentially reducing hospital stay and inflammatory markers in THR/TKR patients.

If you are having hip or knee replacement surgery, ask your surgical team about drinking a specific carbohydrate-rich solution (like a clear maltodextrin drink) the night before and/or 2 hours before your procedure. This is not regular food or water; it is a specific medical protocol designed to reduce surgical stress and speed up recovery. Do not do this unless your medical team approves it, as they will provide the specific type and timing.

GLP-1 receptor ligands improve bone health and reduce fracture risk in type 2 diabetes, with clinical outcomes varying by specific agent.

If you have type 2 diabetes, some GLP-1 drugs like liraglutide and lixisenatide may help protect your bones and reduce fracture risk. However, not all GLP-1 drugs have this effect (e.g., exenatide shows no impact). Discuss your bone health history with your doctor to choose the right medication.

A reduction in the FibroScan-aspartate aminotransferase (FAST) score of at least 0.22 points after 72 weeks of semaglutide treatment is associated with achieving the primary histological endpoint of NASH resolution without worsening of fibrosis.

If you are being treated for NASH with semaglutide, a reduction in your FAST score of 0.22 points or more after 72 weeks is a strong indicator that your liver is improving histologically (NASH resolution without worsening fibrosis). This non-invasive metric may help doctors monitor your progress without requiring repeated liver biopsies, although further validation is needed.

Preoperative administration of GLP-1 receptor agonists (OMMs) serves as an effective bridging therapy for super-obese patients, facilitating technical operability and reducing perioperative complications compared to non-pharmacological methods.

If you are waiting for bariatric surgery and have a very high BMI, ask your doctor about using GLP-1 medications (like liraglutide) beforehand. This can help you lose weight faster and reduce surgical risks, potentially making you eligible for surgery sooner than if you waited without medication.

Exercise stimulates the release of 'exerkines' (signaling molecules like IL-6, 12,13-diHOME, and musclin) that mediate systemic health benefits, including improved cardiac function and metabolic flexibility.

Engaging in regular exercise triggers the release of beneficial signaling molecules (exerkines) from your muscles, fat, and liver that protect your heart and metabolism. You don't need to manage these molecules directly; consistent physical activity is the key to activating them.

Very-low-calorie diets (VLCDs) can induce remission of type 2 diabetes and favorable metabolic profiles in the short term, but long-term sustainability and safety data are lacking.

VLCDs can help some people with type 2 diabetes achieve remission in the short term, but they are not a long-term solution. They require medical supervision and supplementation. Long-term success depends on transitioning to sustainable habits.

Integrating passive stretch into the inter-set rest period of resistance training enhances muscle hypertrophy compared to standard passive rest, particularly in type I muscle fibers, without compromising strength gains.

To potentially maximize muscle growth without extending your workout time, hold a passive stretch for 20-30 seconds immediately after your last rep of each set, during your rest period. Aim for a discomfort level of 8 out of 10. This strategy appears most beneficial for slower-twitch (Type I) muscle fibers and does not appear to negatively impact long-term strength gains.

GLP-1 receptor agonists (GLP-1RAs) induce weight loss and improve metabolic function in patients with hypothalamic obesity (HO), with efficacy potentially independent of the extent of hypothalamic damage.

If you have hypothalamic obesity, standard diets and exercise often fail because the brain's 'thermostat' is broken. GLP-1 medications (like semaglutide or liraglutide) work by targeting brain areas outside the damaged hypothalamus to signal fullness. While results vary, many patients experience significant weight loss and metabolic improvement, especially if the medication is started at a low dose and increased slowly to manage side effects.

GLP-1 receptor agonists accelerate preoperative weight loss in obese patients undergoing elective hernia repair, significantly reducing time to surgery compared to lifestyle modifications alone, without increasing postoperative complication rates.

If you are obese and need hernia surgery, using GLP-1 medications (like semaglutide) alongside diet and exercise can help you reach your weight loss goal much faster than diet and exercise alone. This means you can get your surgery sooner without increasing your risk of complications. Talk to your surgeon about whether this is an option for you, keeping in mind that insurance coverage and cost may be barriers.

Targeting the Ghrelin Receptor (GHSR1a) with inverse agonists or antagonists like LEAP2 reduces food intake and postprandial glucose, offering a potential treatment for type-2 diabetes and obesity.

A new approach to blocking hunger involves a natural peptide called LEAP2. In a small study, giving LEAP2 intravenously reduced how much people ate and lowered their blood sugar after meals. This suggests it might help people with type-2 diabetes or obesity, but more research is needed to see if these benefits last long-term.

Consuming mycoprotein provides a sustained release of essential amino acids (EAAs) and branched-chain amino acids (BCAAs) compared to milk protein, supporting muscle protein synthesis without rapid spikes.

To support muscle growth, include mycoprotein (like Quorn) in your diet. It digests slower than milk or meat, providing a steady stream of amino acids over several hours, which is beneficial for muscle protein synthesis. Aim for 60-80g servings to maximize this effect.

Mycoprotein consumption reduces postprandial insulin response and energy intake at high doses (132g) compared to chicken, without altering glycemic response.

If you are overweight or obese, incorporating mycoprotein into your meals, particularly in larger portions (around 132g of protein), may help reduce your insulin response and naturally lower your calorie intake at the next meal compared to chicken.

A delayed-morning, earlier-evening time-restricted feeding (TRF) protocol (10:00–18:00 h) improves nocturnal glycemic control in men with overweight/obesity compared to extended feeding (07:00–22:00 h), while maintaining positive subjective adherence.

For men with overweight or obesity, shifting your eating window to start at 10:00 AM and end by 6:00 PM can significantly improve blood sugar levels during sleep compared to eating from 7:00 AM to 10:00 PM. This approach is metabolically effective and more socially sustainable than extreme early-fasting protocols, provided you maintain your total calorie and macronutrient intake.

Periodic refeeding (brief overfeeding, primarily carbohydrates) can acutely increase circulating leptin levels, but its effect on increasing Total Daily Energy Expenditure (TDEE) is modest and may not significantly improve long-term weight loss success.

If you are dieting for a long time, a planned refeed day (high carb, slightly above maintenance) might help your leptin levels. However, don't expect it to massively boost your metabolism. It’s a small tool, not a magic bullet.

Supplemental fish oil (4 g/d providing 1,600 mg EPA and 800 mg DHA) for 6 weeks significantly increases fat-free mass and decreases fat mass in healthy adults.

Take 4 grams of fish oil daily (providing 1,600 mg EPA and 800 mg DHA) for 6 weeks. This specific dose was shown to increase lean mass and decrease fat mass in healthy adults, likely by lowering cortisol levels. Maintain your normal diet and exercise habits.

Fish oil supplementation reduces salivary cortisol levels, and this reduction is significantly correlated with increased fat-free mass and decreased fat mass.

Fish oil may help lower cortisol, which is linked to fat gain and muscle loss. This study suggests that by lowering cortisol, fish oil might help you build lean mass and lose fat.

GLP-1 receptor agonists provide cardiovascular benefits, including reduced blood pressure and improved endothelial function, which may occur independently of weight loss.

GLP-1 receptor agonists offer cardiovascular protection beyond just weight loss. They can lower blood pressure and improve blood vessel function, likely through direct effects on the kidneys and blood vessels. These benefits may start appearing within weeks of treatment, even before significant weight loss occurs.

Low carbohydrate diets induce rapid short-term weight loss partly through ketosis (suppressing appetite via ketone bodies) and diuresis (water loss from glycogen depletion), but may increase LDL cholesterol and reduce diet quality due to low fiber intake.

Low carbohydrate diets can lead to rapid initial weight loss due to water loss and appetite suppression from ketones, but long-term adherence is hard and may raise LDL cholesterol. Ensure you get enough fiber from non-starchy vegetables to protect gut health.

Weekly subcutaneous administration of IBI362, a GLP-1 and glucagon receptor dual agonist, produces significant body weight loss and improves metabolic parameters in Chinese adults with overweight or obesity.

IBI362 is a once-weekly injection that helps overweight and obese Chinese adults lose weight and improve metabolic health. It works by targeting two hormones (GLP-1 and glucagon) to reduce appetite and increase energy expenditure. In this study, participants lost between 4.8% and 6.4% of their body weight over 12 weeks, with side effects like nausea being mostly mild. This suggests it is a viable option for those seeking pharmacological weight loss support.

Time-restricted eating (TRE), specifically early TRE, can improve cardiometabolic markers such as blood pressure and glucose control even in the absence of weight loss (eucaloric conditions).

If you have prediabetes, try eating within an early window (e.g., 8 am to 4 pm) without changing your total calories. You might see improvements in blood pressure and blood sugar control even if your weight stays the same.

Performing low-load resistance exercise (30% 1RM) to volitional fatigue during periods of physical inactivity preserves type II muscle fiber cross-sectional area and satellite cell content in older adults.

If you are older and forced to be inactive (e.g., due to injury or illness), do not stop exercising. Perform resistance exercises with light weights (about 30% of your max) until you are completely exhausted. Do this three times a week. This will help you keep your muscle size and health, especially in your fast-twitch muscle fibers, which are most likely to shrink when you stop moving.